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ABSTRACT: The main objective of this study is to note the changes that occur in the lipid 
profile levels following an acute myocardial ischemic attack and also correlate the changes 
in the lipid profile levels to the ischemic markers (Cardiac troponin-I and AST). The study 
included two groups; the first group consisted of 50 patients who were admitted to the 
hospital with Acute Myocardial Infarction (AMI). The second group patients were normal 
healthy controls. Serum levels of Cardiac troponin-I (cTnI) and AST were assessed 
immediately and 12hrs fasting blood drawn for assessing the lipid profile levels. The 
patients with AMI had shown significant rise in cTnI and AST and the lipid parameters 
like High density lipoprotein (HDL) had shown significant decrease and the Very Low 
Density Lipoprotein (VLDL) and triglycerides (TG) had shown significant increase in 
cases compared to normal healthy individuals. Total Cholesterol (TC) and Low Density 
Lipoprotein (LDL) in cases had shown decrease compare to controls but not significant 
statistically. The cTnI showed a significant negative correlation with decrease in the TC 
and HDL and LDL. The AST showed significant negative correlation with TC and LDL 
only. So routine diagnosis of lipid parameter for assessing the clinical risk should be 
reliably assessed within 24 hours and the lipid parameters assessed after 24 hours are 
invalid for risk assessment for patients with AMI. 
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INTRODUCTION
ᴪ 
 
Coronary artery disease (CAD) is one of the 
leading causes of ischemic heart disease and 
remains the most common cause of death despite 
significant advancements in prevention and 
treatment. Several risk factors (smoking, 
hypertension, diabetes, obesity etc.) play a major 
role in the development of CAD
1,2. High levels of 
TC, LDL and TG and low levels of HDL cause 
deposition of lipid in arteries thus causing 
atherosclerosis. So lipid profiles are routinely 
measured for risk assessment in preventing CAD
3. 
                                                            
ᴪCorrespondence at: H.N: 8-324, Bargavapeta, 
Mangalagiri, Guntur, Andra Pradesh, India; 
Mobile: +917299131483; E-mail: 
krishna262424@gmail.com  
The oxidation of LDL cholesterol is considered as 
the most important risk factor for CAD, which 
plays a central role in atherogenesis
4. Macrophages 
uptake of modified LDL results in the formation of 
foam cells, the hallmark cells of atherosclerosis. 
The foam cells and macrophages release growth 
factors and metalloproteinases that lead to cell 
proliferation, extracellular matrix degeneration, 
atherosclerotic plaque instability and plaque 
rupture, the cause for myocardial infarction
5. 
Myocardial ischemia results from the reduction of 
coronary flow to myocardial tissue to such an 
extent that supply of oxygen to the myocardium 
does not meet demand. When this ischemia is 
prolonged and irreversible then myocardial cell 
death and necrosis occurs
6. Due to the tissue injury 
various local and systemic reactions like 
vasodilatation, leukocyte infiltration and Reddy et al / Lipid profile levels on the second day of acute myocardial infarction 
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chemostasis occur and monocytes and 
macrophages activation and cytokines are released. 
So acute phasic changes occur that alter the lipid 
profile levels post MI. Therefore the validity of 
plasma lipids measured beyond 24 hours from the 
onset of MI has been questioned by many studies
3. 
There are several markers for diagnosing AMI, but 
early and accurate diagnosis is essential in the 
management of AMI. Sensitive and specific 
laboratory markers are very important in this 
situation. Due to the ischemia the myocardial cells 
get damaged. The troponins are released from the 
damaged myocardial cells so that cardiac troponins 
(cTns) appear in the blood as early as 3-4 hours of 
an acute episode and remain elevated for 4-14 days. 
When myocardial cells are damaged the cytosolic 
troponins reach the blood stream quickly resulting 
in a rapid peak of serum troponin levels during the 
first few hours. The cTnI, a sensitive and specific 
marker of myocardial injury can be used for 
diagnosing AMI easily and accurately
6,7. The levels 
of cTnI levels in plasma provoke degree of infarct 
size of the myocardial damage due to ischemia. 
The study is to evaluate the changes in lipid profile 
levels during AMI and correlating the changes in 
lipid parameters to the cTnI levels and finally to 
note the post ischemic effect of AMI on the lipid 
parameters. 
 
METHODOLOGY 
 
The study was carried out on patients admitted with 
symptoms of cardiac ischemia and chest pain to 
Coronary Care Unit (CCU), NRI Heart Research 
Centre at NRI General Hospital. The study 
consisted of two groups. Group-I (n=50), consisting 
of patients with ischemic attack and symptoms of 
chest pain were taken as cases. and Group-II 
(n=50), consisting of normal healthy individuals 
were taken as controls. Basic information like age, 
weight, risk factors, lifestyle etc., was recorded 
from the individuals according to a questionnaire. 
Blood samples were collected from the patients 
after obtaining written consent. 
Patients with end stage renal disease, sepsis, 
pericarditis, pulmonary embolism etc were 
excluded from the study. Patients with cardiac 
ischemia with ECG showing ST segment elevation 
were included in the study. After the patient was 
admitted to the CCU, blood samples were drawn 
and centrifuged and serum was separated and used 
for estimation of cTnI and AST. 12 hours fasting 
blood samples were drawn from the patients to 
estimate lipid parameters like TC, HDL and TG. 
All the samples drawn on second day of post MI 
were used for the study. 
The cTnI was estimated quantitatively using Advia 
Centaur CP a fully automated hormone analyser 
(Chemiluminescence technique) and the AST and 
lipid parameters were estimated quantitatively 
using Dade Behring Dimension a fully automated 
chemistry analyser (Bayers technology). The LDL 
and VLDL values were derived indirectly using 
Friedwalds equation. Prior to the estimation of 
samples all the autoanalyzers were calibrated and 
the controls values limits of ±2SD was used for the 
samples estimation.  All the results were tabulated 
and statistical analysis was done using SPSS 
Software 17.0 and Pearson correlation was used for 
correlating different parameters. The p-value of 
˂0.05 was considered to be statistically significant. 
 
RESULTS 
 
Age and sex distribution of the study subjects of 
both groups are presented in Table 1. 
 
Table 1: Mean age, number of males and 
females of cases and controls 
 
Parameters 
Cases 
Mean ±SD  
(n=50) 
Controls 
Mean ±SD 
(n=50) 
Age yrs  54.76±13.8 51.42±13.85 
Number of 
males and 
females 
Male 41 Male 30 
Female 09 Female 20 
 
It is evident from Table 2 that cTnI showed a 
highly significant increase (p ˂0.001) in cases 
compared to controls, as it is a good marker of 
AMI, similarly AST also showed a highly 
significant increase (p ˂0.001) in AMI patients. 
The TC and LDL levels showed slight decrease in 
cases compared to controls but this was not 
statistically significant (p ˃0.05). HDL showed 
significant decrease (p ˂0.001) and the VLDL and 
TG showed a significant increase (p ˂0.001) in 
cases compared to controls. 
Correlation study (Table 3) revealed significant 
positive correlation between cTnI and AST (r= 
0.542, p ˂0.001) and cTnI significant negative 
correlation with TC, HDL, and LDL (r= -0.638, p 
˂0.001; r= -0.287, p 0.043; r= -0.570, p ˂0.001). 
Similarly the AST also showed significant negative 
correlation with the TC and LDL (r= -0.498, p 
˂0.001; r= -0.483, p ˂0.001) only. 
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Table 2: Mean±SD and p value of different parameters of cases and controls 
 
Parameters  Cases (n=50) 
Mean ±SD 
Controls (n=50) 
Mean ±SD  p value 
cTnI ng/ml  53.95±15.2 0.037±0.25  ˂0.001 
AST U/L  290.4±122.5 25.5±6.21  ˂ 0.001 
TC mg/dl  157.9±38.42 166.2±25.8  0.205 
HDL mg/dl  35.38±10.20 43.08±6.35  ˂ 0.001 
LDL mg/dl  98.6±33.45 100.28±24.47  0.776 
VLDL mg/dl  24.39±10.21 20.29±6.20  0.009 
TG mg/dl  121.86±50.9 99.80±26.9  0.007 
 
Table 3: Pearson correlation (r) values for MDA and Vitamin-C with different parameters 
 
Parameters  AST 
U/L 
TC 
mg/dl 
HDL 
mg/dl 
LDL 
mg/dl 
VLDL 
mg/dl 
TG 
mg/dl 
cTnI ng/ml  0.542
** -0.638
**  -0.287
* -0.570
** -0.180  -0.181 
AST U/L  1 -0.498
** -0.215 -0.483
** -0.045  -0.044 
(**p˂0.001; *p<0.05) 
 
DISCUSSION 
 
The root cause of AMI is mainly atherosclerosis. 
Contrary to earlier belief, research in the last two 
decades has shown that atherosclerosis is neither a 
degenerative disease nor inevitable due to ageing. 
On the contrary, atherosclerosis seems to be a 
chronic inflammatory condition that is converted to 
an acute clinical event by induction of plaque 
rupture which in turn leads to thrombosis. Hence 
inflammation occupies a very important central 
position in all phases of atherosclerosis, although 
inflammation must smoulder for decades before 
resulting in a clinical event like AMI
8, 9.  
The lipid abnormality is one important risk factor 
for Ischemic heart disease. There are a number of 
risk factors which influence the formation of 
plaques due to excess cholesterol. The plaques that 
are deposited on the walls of the blood vessels   
reduce blood flow to the heart muscle and cause 
ischemia
10. Due to the ischemia the myocardial 
cells are damaged. The troponins are released from 
the damaged myocardial cells and the cardiac 
troponins (cTns) reach the blood stream quickly 
resulting in a rapid peak of serum troponin levels in 
the first few hours
6, 7. The cTnI is more specific for 
myocardial injury compared to cTnT
6, 7. The cTnI 
had shown highly significant rise in our study with 
about a thousand-fold rise in the serum of patients 
with AMI compared to controls. The AST is 
another traditional cardiac enzyme which has been 
used as one of the markers for AMI. But the 
specificity is poor with a lot of false positive 
elevations (Skeletal injury, Liver damage, 
pulmonary embolism etc.). Since it offers no 
traditional benefits for the diagnosis of AMI, it is 
no longer used as a routine test
7. However the AST 
levels showed a significant rise in cases compared 
to controls with about 10-fold rise. The correlation 
study showed significant positive correlation 
between AST and cTnI (r= 0.542, p˂0.001). The 
false positive rise of AST in the patients was 
avoided by excluding the patients with skeletal 
injury, liver damage, and pulmonary embolism. 
Decreased HDL and rise in TC and LDL is the 
main cause for atherosclerosis
11. However there are 
several risk factors that enhance atherosclerosis, so 
lipid parameters should be checked for risk 
assessment and its management. But the diagnosis 
of lipid parameters in AMI patients in our study 
assessed on the second day has showed a decrease 
in serum levels of TC, HDL and LDL and rise in 
VLDL and TG levels. The TC and LDL are 
decreased in the cases compared to controls, but 
not significantly (Table 2). But the correlation 
study has showed significant negative correlation 
of TC and LDL with cTnI and AST (Table 3), 
which indicates that the decrease in cholesterol is 
indirectly proportional to the ischemic attack. HDL 
showed a significant decrease in cases compared to 
controls and correlation study also showed 
significant negative correlation with cTnI only. The 
decrease in HDL levels is indirectly proportional to 
the cTnI which indicates the post ischemic attack 
effect. 
Thus our study noted a significant alteration in 
serum HDL, VLDL and TG after AMI. However, 
we did not find significant changes in serum TC 
and LDL levels in our study, which is similar to the 
studies of Nigam et al
4 and Wattansuwan et al
3. Reddy et al / Lipid profile levels on the second day of acute myocardial infarction 
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The TC and LDL showed slight decrease in cases 
compared to healthy controls but not significantly. 
Statistically the decrease was not significant, but 
we suggest that it was a decrease because all the 
patients hospitalized with AMI previously had at 
least one risk factor which provokes lipid profile 
levels (high TC, LDL, TG and low HDL levels). 
Due to the ischemic attack the TC and LDL has 
decreased on the second day of AMI in cases and 
was parallelised with the values of controls, and 
when  cases were compared to normal healthy 
controls it was noted as not statistically significant,. 
But clinically when we note the changes in the 
same patients with AMI before and after MI, we 
can note the statistical decrease in TC and LDL 
levels. That is the limitation of our study. However 
studies of Swedarsen et al
12 have showed 
significant decrease in the levels of TC from the 
day-1 of MI to day-2 in the same patients. 
However, there have been many studies in the past 
few decades which show that AMI results in a 
significant decrease in TC, HDL and LDL. So the 
acceptable time for the measurement of plasma 
lipids after an AMI is within 24 hours after the 
onset of symptoms, and the plasma lipid levels 
measured beyond 24 hours are mostly considered 
to be invalid
3,4,11. The changes in the lipid 
parameters following AMI are due to acute phase 
response. AMI, like any other tissue injury, initiates 
various local and systemic reactions. The cytokines 
act on systemic targets, including the liver, to 
generate changes in the concentration of various 
heterogeneous plasma proteins that are known 
collectively as acute phase reactants, including 
lipoproteins and C-reactive proteins. By day 4 to 5 
after MI there is a significant decrease in the serum 
concentration of apoprotein A-I and apoprotein B, 
reflecting the maximum decrease in serum TC, 
HDL, and LDL
3. Kenneth et al state that acute 
phase response induces marked changes in lipid 
metabolism like increased plasma triglyceride 
levels and decreased HDL levels
14. Hollanders et al 
state that increased catecholamine secretion after 
MI may be implicated in the serum lipid 
alteration
15. 
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